← Back to companies

Nabla Bio
Biotech/Pharma0 open
21+ employeesSeries A raised
Backed by
Fifty YearsZetta Venture Partners
Nabla Bio is building an end-to-end antibody creation platform. Nabla Bio is applying natural language processing algorithms to amino acids generating a predictive “biophysical fingerprint” for 1 million antibodies in a single step.
Open Positions at Nabla Bio (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Nabla Bio?